Get started
Author

Sarah Cavaillon

Observed names: S. Cavaillon, Sarah CAVAILLON
ORCID: 0009-0006-1904-2130
Observed ORCID: 0009-0006-1904-2130
OpenAlex ID: A5088709286
Artificial intelligence–driven microsatellite instability profiling reveals distinctive genetic features in patients with lung cancer
2025 · Quentin Dominique Thomas, Julie Adèle Vendrell, et al. · Cancer · 9
PDF
Optimizing Treatment Strategies for Egfr-Mutated Non-Small-Cell Lung Cancer Treated with Osimertinib: Real-World Outcomes and Insights
2024 · Quentin Dominique Thomas, Nicolas Girard, et al. · Cancers · 6
312P Efficacy of sequential antibody-drug conjugates (ADCs) targeting topoisomerase-1 in HER2-low metastatic breast cancer (MBC): Updated results and additional analyses from the French multicenter retrospective ADC-low cohort
2025 · F. Poumeaud, M. Morisseau, et al. · ESMO Open · 3
PDF
Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative Study
2024 · thomasqicm THOMAS, Mohamed CHAABOUNI, et al. · Cancers · 3
PDF
IMMUNORARE 5 : A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The B3 Thymomas and Thymic Carcinomas Cohort.
2025 · Michaël Duruisseaux, Benjamin Besse, et al. · Journal of Clinical Oncology · 2
PDF
Abstract PD3-08: Evidence Accumulates Against Sequencing Topo1-ADCs in HER2-Low Metastatic Breast Cancers: results from International, retrospective, real-world ADC-Low-Europe cohort
2026 · F. Poumeaud, M. Morisseau, et al. · Clinical Cancer Research · 1
ctDNA Detection of Polyclonal KRAS Resistance in Adagrasib‐Treated NSCLC
2026 · Marion Caumeil, Julie A. Vendrell, et al. · Thoracic Cancer
446P Real-world outcomes in patients with advanced breast cancer according to endocrine sensitivity/resistance definitions: A multicenter retrospective study from the ESME cohort
2026 · S. Cavaillon, E. Teruel, et al. · ESMO Open
PDF
982P First-in-human clinical trial of the acetylglucosaminyltransferase V (GnT-V) inhibitor PhOx430 in patients with advanced solid tumours: the PhAST trial
2025 · D. Tosi, I. Corbeau, et al. · Annals of Oncology
1530P Outcome of primary soft tissue or bone myoepithelial tumors (METs)
2021 · S. Cavaillon, M. Toulmonde, et al. · Annals of Oncology
PDF
Works count: 10
Citation count: 24
H-index: 3
I10-index:
Year
Topic
Type